Skip to main content

Published locations for Nivolumab plus ipilimumab shines as first-line in advanced NSCLC

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Nivolumab plus ipilimumab shines as first-line in advanced NSCLC

User login

  • Reset your password
  • /content/nivolumab-plus-ipilimumab-shines-first-line-advanced-nsclc
  • /pulmonary-health-hub/article/119553/lung-cancer/nivolumab-plus-ipilimumab-shines-first-line-advanced
  • /oncologypractice/article/119553/lung-cancer/nivolumab-plus-ipilimumab-shines-first-line-advanced
  • /node/155702/article/119553/lung-cancer/nivolumab-plus-ipilimumab-shines-first-line-advanced-nsclc
  • /hematology-oncology/article/119553/lung-cancer/nivolumab-plus-ipilimumab-shines-first-line-advanced
  • /chestphysician/article/119553/lung-cancer/nivolumab-plus-ipilimumab-shines-first-line-advanced-nsclc